Crystal structure of epstein-barr virus DNA polymerase processivity factor BMRF1. 2009

Kazutaka Murayama, and Sanae Nakayama, and Miyuki Kato-Murayama, and Ryogo Akasaka, and Naomi Ohbayashi, and Yuki Kamewari-Hayami, and Takaho Terada, and Mikako Shirouzu, and Tatsuya Tsurumi, and Shigeyuki Yokoyama
Division of Biomedical Measurements and Diagnostics, Graduate School of Biomedical Engineering, Tohoku University, Sendai 980-8575.

The DNA polymerase processivity factor of the Epstein-Barr virus, BMRF1, associates with the polymerase catalytic subunit, BALF5, to enhance the polymerase processivity and exonuclease activities of the holoenzyme. In this study, the crystal structure of C-terminally truncated BMRF1 (BMRF1-DeltaC) was solved in an oligomeric state. The molecular structure of BMRF1-DeltaC shares structural similarity with other processivity factors, such as herpes simplex virus UL42, cytomegalovirus UL44, and human proliferating cell nuclear antigen. However, the oligomerization architectures of these proteins range from a monomer to a trimer. PAGE and mutational analyses indicated that BMRF1-DeltaC, like UL44, forms a C-shaped head-to-head dimer. DNA binding assays suggested that basic amino acid residues on the concave surface of the C-shaped dimer play an important role in interactions with DNA. The C95E mutant, which disrupts dimer formation, lacked DNA binding activity, indicating that dimer formation is required for DNA binding. These characteristics are similar to those of another dimeric viral processivity factor, UL44. Although the R87E and H141F mutants of BMRF1-DeltaC exhibited dramatically reduced polymerase processivity, they were still able to bind DNA and to dimerize. These amino acid residues are located near the dimer interface, suggesting that BMRF1-DeltaC associates with the catalytic subunit BALF5 around the dimer interface. Consequently, the monomeric form of BMRF1-DeltaC probably binds to BALF5, because the steric consequences would prevent the maintenance of the dimeric form. A distinctive feature of BMRF1-DeltaC is that the dimeric and monomeric forms might be utilized for the DNA binding and replication processes, respectively.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D004259 DNA-Directed DNA Polymerase DNA-dependent DNA polymerases found in bacteria, animal and plant cells. During the replication process, these enzymes catalyze the addition of deoxyribonucleotide residues to the end of a DNA strand in the presence of DNA as template-primer. They also possess exonuclease activity and therefore function in DNA repair. DNA Polymerase,DNA Polymerases,DNA-Dependent DNA Polymerases,DNA Polymerase N3,DNA Dependent DNA Polymerases,DNA Directed DNA Polymerase,DNA Polymerase, DNA-Directed,DNA Polymerases, DNA-Dependent,Polymerase N3, DNA,Polymerase, DNA,Polymerase, DNA-Directed DNA,Polymerases, DNA,Polymerases, DNA-Dependent DNA
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D014764 Viral Proteins Proteins found in any species of virus. Gene Products, Viral,Viral Gene Products,Viral Gene Proteins,Viral Protein,Protein, Viral,Proteins, Viral
D017434 Protein Structure, Tertiary The level of protein structure in which combinations of secondary protein structures (ALPHA HELICES; BETA SHEETS; loop regions, and AMINO ACID MOTIFS) pack together to form folded shapes. Disulfide bridges between cysteines in two different parts of the polypeptide chain along with other interactions between the chains play a role in the formation and stabilization of tertiary structure. Tertiary Protein Structure,Protein Structures, Tertiary,Tertiary Protein Structures
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies

Related Publications

Kazutaka Murayama, and Sanae Nakayama, and Miyuki Kato-Murayama, and Ryogo Akasaka, and Naomi Ohbayashi, and Yuki Kamewari-Hayami, and Takaho Terada, and Mikako Shirouzu, and Tatsuya Tsurumi, and Shigeyuki Yokoyama
June 2013, Journal of virology,
Kazutaka Murayama, and Sanae Nakayama, and Miyuki Kato-Murayama, and Ryogo Akasaka, and Naomi Ohbayashi, and Yuki Kamewari-Hayami, and Takaho Terada, and Mikako Shirouzu, and Tatsuya Tsurumi, and Shigeyuki Yokoyama
May 2017, Journal of virology,
Kazutaka Murayama, and Sanae Nakayama, and Miyuki Kato-Murayama, and Ryogo Akasaka, and Naomi Ohbayashi, and Yuki Kamewari-Hayami, and Takaho Terada, and Mikako Shirouzu, and Tatsuya Tsurumi, and Shigeyuki Yokoyama
September 2004, The Journal of biological chemistry,
Kazutaka Murayama, and Sanae Nakayama, and Miyuki Kato-Murayama, and Ryogo Akasaka, and Naomi Ohbayashi, and Yuki Kamewari-Hayami, and Takaho Terada, and Mikako Shirouzu, and Tatsuya Tsurumi, and Shigeyuki Yokoyama
December 1994, Cell,
Kazutaka Murayama, and Sanae Nakayama, and Miyuki Kato-Murayama, and Ryogo Akasaka, and Naomi Ohbayashi, and Yuki Kamewari-Hayami, and Takaho Terada, and Mikako Shirouzu, and Tatsuya Tsurumi, and Shigeyuki Yokoyama
March 1995, Journal of virology,
Kazutaka Murayama, and Sanae Nakayama, and Miyuki Kato-Murayama, and Ryogo Akasaka, and Naomi Ohbayashi, and Yuki Kamewari-Hayami, and Takaho Terada, and Mikako Shirouzu, and Tatsuya Tsurumi, and Shigeyuki Yokoyama
March 2000, Journal of molecular biology,
Kazutaka Murayama, and Sanae Nakayama, and Miyuki Kato-Murayama, and Ryogo Akasaka, and Naomi Ohbayashi, and Yuki Kamewari-Hayami, and Takaho Terada, and Mikako Shirouzu, and Tatsuya Tsurumi, and Shigeyuki Yokoyama
January 1999, The Journal of general virology,
Kazutaka Murayama, and Sanae Nakayama, and Miyuki Kato-Murayama, and Ryogo Akasaka, and Naomi Ohbayashi, and Yuki Kamewari-Hayami, and Takaho Terada, and Mikako Shirouzu, and Tatsuya Tsurumi, and Shigeyuki Yokoyama
April 1983, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
Kazutaka Murayama, and Sanae Nakayama, and Miyuki Kato-Murayama, and Ryogo Akasaka, and Naomi Ohbayashi, and Yuki Kamewari-Hayami, and Takaho Terada, and Mikako Shirouzu, and Tatsuya Tsurumi, and Shigeyuki Yokoyama
December 1994, Uirusu,
Kazutaka Murayama, and Sanae Nakayama, and Miyuki Kato-Murayama, and Ryogo Akasaka, and Naomi Ohbayashi, and Yuki Kamewari-Hayami, and Takaho Terada, and Mikako Shirouzu, and Tatsuya Tsurumi, and Shigeyuki Yokoyama
January 2005, Journal of virology,
Copied contents to your clipboard!